Skip to main content
Log in

Focal cerebral ischemia induces Alzheimer’s disease-like pathological change in rats

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

The changes in the tau protein phosphorylation and expression of bcl-2, and bax in rat parietal cortex neurons after focal cerebral ischemia-reperfusion (I/R) were explored, and the relationship between the tau protein phosphorylation and the expression of bax or apoptosis was clarified in order to elucidate the relationship between cerebral infarction and Alzheimer’s disease. The rat focal cerebral I/R model was induced by occlusion of the right middle cerebral artery using the intraluminal suture method. The level of tau protein phosphorylation at Ser396, Ser404, Tyr231, Ser199/202 sites and the expression of bcl-2, bax and total tau 5 in rat parietal cortex during focal cerebral ischemia/reperfusion were detected by Western blot. The relationship between the tau protein phosphorylation and the expression of bax, or apoptosis was examined by TUNEL method and double-labeling immunofluorenscence method. The results showed that the level of tau hyperphosphorylation at Ser199 / 202, Ser396, Ser404, Tyr231 sites and the expression levels of bcl-2, and bax were significantly higher in I/R group than in the sham group, but the ratio of bcl-2/bax was decreased. Neuronal apoptosis, bax expression and the tau protein hyperphosphorylation were co-localized. It is suggested that Alzheimer’s disease-like pathological changes occur after cerebral I/R. The highly abnormal phosphorylation of tau protein plays a key role in cerebral I/R-induced apoptosis. The cerebral infarction may contribute to Alzheimer’s disease occurrence and development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kalaria R. Similarities between Alzheimer’s disease and vascular dementia. J Neurol Sci, 2002,203–205(29–34):29–34

    Article  Google Scholar 

  2. Tatemichi TK, Desmond DW, Mayeux R, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology, 1992,42(6):1185–1193

    CAS  PubMed  Google Scholar 

  3. Tatemichi TK, Paik M, Bagiella E, et al. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology, 1994,44(10):1885–1891

    CAS  PubMed  Google Scholar 

  4. De la Torre JC. Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol, 2004,3(3):184

    Article  PubMed  Google Scholar 

  5. Götz J, Chen F, van Dorpe J, et al. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science, 2001,293(5534):1446–1447

    Article  Google Scholar 

  6. Kobayashi K, Nakano H, Hayashi M, et al. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer’s disease. J Neurol Sci, 2003,208(1–2):17–24

    Article  CAS  PubMed  Google Scholar 

  7. MacGibbon GA, Lawlor PA, Sirimanne ES, et al. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer’s disease hippocampus. Brain Res, 1997,750(1–2):223–234

    Article  CAS  PubMed  Google Scholar 

  8. Tortosa A, Lopea E, Ferrer I. Bcl- 2 and Bax protein expression in Alzheimer’s disease. Acta Neuropathol, 1998,95(4):407–412

    Article  CAS  PubMed  Google Scholar 

  9. Zhao H, Yenari MA, Cheng D, et al. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem, 2003,85(4):1026–1036

    Article  CAS  PubMed  Google Scholar 

  10. Zhu Y, Prehn J, Clumsee C, et al. The beta-2-adrnoceptor agonist clenbuterol modulates Bcl-2, Bcl-xl and Bax protein expression following transient forebrain ischemia. Neuroscience, 1999,90(4):1255–1263

    Article  CAS  PubMed  Google Scholar 

  11. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989,20(1):84–91

    CAS  PubMed  Google Scholar 

  12. Shawn NW, Vladimir CH, David FC, et al. Interaction between a rat model of cerebral ischemia and β- amyloid toxicity. Inflammatory Responses, Stroke, 2005,36(1):107–112

    Article  CAS  Google Scholar 

  13. Li J, Wang YJ, Zhang M, et al. Effect of cerebral ischemia on the expression of abnormally phosphorylated tau protein in cortical and hippocampal neurons of AD rats. Chongqing Med (Chinese), 2008,37(7):678–682

    CAS  Google Scholar 

  14. Ehehalt R, Keller P, Haass C, et al. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol, 2003,160(1):113–123

    Article  CAS  PubMed  Google Scholar 

  15. Honig LS, Kukull W, Mayeux R, et al. Atherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating Center. Neurology, 2005,64(3):494–500

    PubMed  Google Scholar 

  16. Bellew KM, Pigeon JG, Stang PE, et al. Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type. Alzheimer Dis Assoc Disord, 2004,18(4):208–213

    PubMed  Google Scholar 

  17. Kopke E, Tung YC, Shaikh S, et al. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem, 1993, 268(32):24 374–24 384

    CAS  Google Scholar 

  18. Cardona-Gómez GP, Arango-Davila C, Gallego-Gómez JC, et al. Estrogen dissociates Tau and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor subunit in postischemic hippocampus. Neuroreport, 2006,17(12):1337–1341

    Article  PubMed  CAS  Google Scholar 

  19. Ikeda K, Akiyama H, Arai T, et al. Neurons containing Alz-50-immunoreactive granules around the cerebral infarction: evidence for the lysosomal degradation of altered tau in human brain? Neurosci Lett, 2000,284(3):187–189

    Article  CAS  PubMed  Google Scholar 

  20. Wen Y, Yang SH, Liu R, et al. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Research, 2004,1022(1–2):30–38

    Article  CAS  PubMed  Google Scholar 

  21. Gong CX, Wegiel J, Lidsky T, et al. Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain. Brain Res, 2000,853(2):299–309

    Article  CAS  PubMed  Google Scholar 

  22. Roth KA. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol, 2001,60(9):829–838

    CAS  PubMed  Google Scholar 

  23. Katsuji K, Hiroyuki N, Masahiro H, et al. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer’s disease. J Neurol Sci, 2003, 208(1–2):17–24

    Google Scholar 

  24. MacGibbon GA, Lawlor PA, Sirimanne ES, et al. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer’s disease hippocampus. Brain Res, 1997,750(1):223–234

    Article  CAS  PubMed  Google Scholar 

  25. Guise S, Braguer D, Carles G, et al. Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblstoma cells. Neurosci Res, 2001,63(3):257–267

    Article  CAS  Google Scholar 

  26. Tortosa A, Lopea E, Ferrer I, et al. Bcl- 2 and Bax protein expression in Alzheimer’s disease. Acta Neuropathol, 1998,95(4):407–412

    Article  CAS  PubMed  Google Scholar 

  27. Chen LQ, Wei JS, Lei ZN, et al. Induction of Bcl-2 and Bax was related to hyperphosphorylation of Tau and neuronal death induced by okadaic acid in rat brain. Anat Rec A Discov Mol Cell Evol Biol, 2005,287A(2):1236–1245

    Article  CAS  Google Scholar 

  28. Eberspacher E, Werner C, Engelhard K, et al. The effect of hypothermia on the expression of the apoptosis-regulating protein Bax after incomplete cerebral ischemia and reperfusion in rats, J Neurosurgy Anesthesiol, 2003,15(3):200–208

    Article  Google Scholar 

  29. Amemiya S, Kamiya T, Nito C, et al. Anti-apoptotic and neuro-protective effect of edaiavone following transient focal ischemia in rats. Eur J Pharmacol, 2005,516(2):125–130

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hongyang Zhao  (赵洪洋).

Additional information

This project was supported by a grant from the National Science & Technology Pillar Program in the Eleventh Five-year Period in China (No. 2006BAI01A13).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, H., Zhao, H., Ye, Y. et al. Focal cerebral ischemia induces Alzheimer’s disease-like pathological change in rats. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 30, 29–36 (2010). https://doi.org/10.1007/s11596-010-0106-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-010-0106-4

Key words

Navigation